BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34146456)

  • 1. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China.
    Li H; Ding C; Zeng H; Zheng R; Cao M; Ren J; Shi J; Sun D; He S; Yang Z; Yu Y; Zhang Z; Sun X; Guo G; Song G; Wei W; Chen W; He J
    Cancer Commun (Lond); 2021 Aug; 41(8):715-725. PubMed ID: 34146456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.
    Liu M; Liu Z; Cai H; Guo C; Li X; Zhang C; Wang H; Hang D; Liu F; Deng Q; Yang X; Yuan W; Pan Y; Li J; Zhang C; Shen N; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1538-1546.e7. PubMed ID: 28342951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
    Chen W; Li H; Ren J; Zheng R; Shi J; Li J; Cao M; Sun D; He S; Sun X; Cao X; Feng S; Zhou J; Luo P; Zha Z; Jia S; Wang J; Ma H; Zeng H; Canfell K; He J
    Int J Cancer; 2021 Jan; 148(2):329-339. PubMed ID: 32663318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Prediction Models for Esophageal Squamous Cell Carcinoma in General Population: A Systematic Review and External Validation Study.
    Jiang H; Chen R; Li Y; Hao C; Song G; Hua Z; Li J; Wang Y; Wei W
    Am J Gastroenterol; 2024 May; 119(5):814-822. PubMed ID: 38088388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.
    Chen W; Li H; Zheng R; Ren J; Shi J; Cao M; Sun D; Sun X; Cao X; Zhou J; Luo P; Wang J; Ma H; Shao T; Zhao C; He S; Sun D; Xu Y; Wu P; Zeng H; Li J; He J
    Gastrointest Endosc; 2021 Jan; 93(1):110-118.e2. PubMed ID: 32504698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.
    Hur C; Choi SE; Kong CY; Wang GQ; Xu H; Polydorides AD; Xue LY; Perzan KE; Tramontano AC; Richards-Kortum RR; Anandasabapathy S
    World J Gastroenterol; 2015 May; 21(18):5513-23. PubMed ID: 25987774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.
    He Z; Liu Z; Liu M; Guo C; Xu R; Li F; Liu A; Yang H; Shen L; Wu Q; Duan L; Li X; Zhang C; Pan Y; Cai H; Ke Y
    Gut; 2019 Feb; 68(2):198-206. PubMed ID: 29306867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age at Initiation and Frequency of Screening to Prevent Esophageal Squamous Cell Carcinoma in High-risk Regions: an Economic Evaluation.
    Wu B; Wang Z; Zhang Q
    Cancer Prev Res (Phila); 2020 Jun; 13(6):543-550. PubMed ID: 32152149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
    Xia R; Li H; Shi J; Liu W; Cao M; Sun D; He S; Yu Y; Li N; Lei L; Zhuang G; Chen W
    Gastrointest Endosc; 2022 Feb; 95(2):225-235.e20. PubMed ID: 34418461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
    Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands.
    van Tilburg L; Spaander MCW; Bruno MJ; Oudijk L; Heij LR; Doukas M; Koch AD
    Dis Esophagus; 2023 Nov; 36(12):. PubMed ID: 37480179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal starting age of endoscopic screening for esophageal squamous cell cancer in high prevalence areas in China.
    Feng H; Song G; Ma S; Ma Q; Li X; Wei W; Abnet C; Qiao Y; Wang G
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1761-1768. PubMed ID: 32367575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males.
    Nezu Y; Manabe N; Yoda Y; Haruma K
    United European Gastroenterol J; 2022 Oct; 10(8):868-873. PubMed ID: 35976761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles and Findings of Population-Based Esophageal Cancer Screening With Endoscopy in China: Systematic Review and Meta-analysis.
    Li H; Teng Y; Yan X; Cao M; Yang F; He S; Zhang S; Li Q; Xia C; Li K; Chen W
    JMIR Public Health Surveill; 2023 Jun; 9():e45360. PubMed ID: 37261899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic screening for esophageal squamous cell carcinoma.
    Roshandel G; Nourouzi A; Pourshams A; Semnani S; Merat S; Khoshnia M
    Arch Iran Med; 2013 Jun; 16(6):351-7. PubMed ID: 23725069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial.
    Liu M; Yang W; Guo C; Liu Z; Li F; Liu A; Yang H; Shen L; Wu Q; Duan L; Wang H; Tian H; Shi C; Pan Y; Liu Y; Liu F; Weiss NS; Cai H; He Z; Ke Y
    J Clin Oncol; 2024 May; 42(14):1655-1664. PubMed ID: 38457759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of patients at high-risk of squamous cell esophageal cancer.
    Chaber-Ciopinska A; Kiprian D; Kawecki A; Kaminski MF
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):893-900. PubMed ID: 27938784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China.
    Wei WQ; Hao CQ; Guan CT; Song GH; Wang M; Zhao DL; Li BY; Bai WL; Hou PY; Wang JW; Jin GL; Lei FH; Li XQ; Xue LY; Wang GQ; Abnet CC; Taylor PR; Dawsey SM; Qiao YL
    Am J Gastroenterol; 2020 Jul; 115(7):1036-1044. PubMed ID: 32618654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial.
    Li F; Liu M; Guo C; Xu R; Li F; Liu Z; Pan Y; Liu F; Liu Y; Cai H; He Z; Ke Y
    Front Oncol; 2022; 12():1002693. PubMed ID: 36531057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey.
    He Z; Zhao Y; Guo C; Liu Y; Sun M; Liu F; Wang X; Guo F; Chen K; Gao L; Ning T; Pan Y; Li Y; Zhang S; Lu C; Wang Z; Cai H; Ke Y
    Br J Cancer; 2010 Sep; 103(7):1085-8. PubMed ID: 20700119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.